See how top analysts and institutions rate CTVA — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | 2025-10-03 | |
| Citigroup | Downgrade | Buy → Neutral | $70 | 2025-10-02 |
| JP Morgan | Upgrade | Neutral → Overweight | $67 | 2025-10-02 |
| Barclays | Upgrade | Equal Weight → Overweight | $84 | 2025-08-13 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 5 | 13 | 5 | 0 | 0 |
| October 2025 | 5 | 13 | 5 | 0 | 0 |
| September 2025 | 3 | 15 | 5 | 0 | 0 |
| August 2025 | 3 | 15 | 5 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for CTVA, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
